This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bellido, T. Articles by Manolagas, S. C. Search for Related Content PubMed PubMed Citation Articles by Bellido, T. Articles by Manolagas, S. C.

Activation of the Janus Kinase/STAT (Signal Transducer and Activator of Transcription) Signal Transduction Pathway by Interleukin-6-Type Cytokines Promotes Osteoblast Differentiation¹

Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the McClellan Veterans Administration Medical Center, Geriatric Research, Education, and Clinical Center, Little Rock, Arkansas 72205

Address all correspondence and requests for reprints to: Teresita Bellido, Ph.D., Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, 4301 West Markham, Mail Slot 587, Little Rock, Arkansas 72205. E-mail: TMBELLIDO{at}LIFE.UAMS.EDU

We have previously established that stromal/osteoblastic cells collectively express receptors for all members of the cytokine subfamily that share the gp130 signal transducer and that different receptor repertoires may be expressed at different stages of differentiation of this lineage. We have now used human (MG-63) and murine (MC3T3-E1) osteoblastic cell lines as well as primary murine calvaria cells to test the hypothesis that these receptors mediate effects of the cytokines on the biology of osteoblasts. We report that as in other cell types, all of the osteoblastic cell models responded to interleukin-6 (IL-6)-type cytokines with activation of both the JAK/STAT (Janus kinase/signal transducer and activator of transcription) and the mitogen-activated protein kinase (MAPK) pathways. In addition, IL-6-type cytokines stimulated alkaline phosphatase activity and osteocalcin expression and inhibited (MG-63), stimulated (MC3T3-E1), or had no effect (calvaria cells) on the rate of cell proliferation. The ability of a given cell type to respond to a particular member of this family of cytokines was strictly dependent on the presence of the corresponding ligand-binding subunit () of the cytokine receptor, and the magnitude of all the effects was closely correlated with the concentration of this subunit. The relative contribution of the JAK/STAT and MAPK pathways to the biological effects of the cytokines was evaluated using kinase inhibitors. Cytokine-mediated modulation of cell proliferation as well as stimulation of alkaline phosphatase activity were abrogated by tyrosine kinase inhibitors as well as a threonine/serine kinase inhibitor, but were only minimally affected by a specific inhibitor of MAPK phosphorylation. These results demonstrate that IL-6-type cytokines, besides their osteoclastogenic properties, promote differentiation of committed osteoblastic cells toward a more mature phenotype and that this action is mediated primarily via the activation of the JAK/STAT pathway.

This article has been cited by other articles:

				L. I. Plotkin, J. I. Aguirre, S. Kousteni, S. C. Manolagas, and T. Bellido Bisphosphonates and Estrogens Inhibit Osteocyte Apoptosis via Distinct Molecular Mechanisms Downstream of Extracellular Signal-regulated Kinase Activation J. Biol. Chem., February 25, 2005; 280(8): 7317 - 7325. [Abstract] [Full Text] [PDF]

				A. M. Kennedy, K. L. Shogren, M. Zhang, R. T. Turner, T. C. Spelsberg, and A. Maran 17{beta}-Estradiol-Dependent Activation of Signal Transducer and Activator of Transcription-1 in Human Fetal Osteoblasts Is Dependent on Src Kinase Activity Endocrinology, January 1, 2005; 146(1): 201 - 207. [Abstract] [Full Text] [PDF]

				L. Xiao, T. Naganawa, E. Obugunde, G. Gronowicz, D. M. Ornitz, J. D. Coffin, and M. M. Hurley Stat1 Controls Postnatal Bone Formation by Regulating Fibroblast Growth Factor Signaling in Osteoblasts J. Biol. Chem., June 25, 2004; 279(26): 27743 - 27752. [Abstract] [Full Text] [PDF]

				H.-I. Shin, P. Divieti, N. A. Sims, T. Kobayashi, D. Miao, A. C. Karaplis, R. Baron, R. Bringhurst, and H. M. Kronenberg gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro Endocrinology, March 1, 2004; 145(3): 1376 - 1385. [Abstract] [Full Text] [PDF]

				S. Kim, T. Koga, M. Isobe, B. E. Kern, T. Yokochi, Y. E. Chin, G. Karsenty, T. Taniguchi, and H. Takayanagi Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation Genes & Dev., August 15, 2003; 17(16): 1979 - 1991. [Abstract] [Full Text] [PDF]

				F. Legendre, J. Dudhia, J.-P. Pujol, and P. Bogdanowicz JAK/STAT but Not ERK1/ERK2 Pathway Mediates Interleukin (IL)-6/Soluble IL-6R Down-regulation of Type II Collagen, Aggrecan Core, and Link Protein Transcription in Articular Chondrocytes. ASSOCIATION WITH A DOWN-REGULATION OF SOX9 EXPRESSION J. Biol. Chem., January 24, 2003; 278(5): 2903 - 2912. [Abstract] [Full Text] [PDF]

				C. Vermes, J. J. Jacobs, J. Zhang, G. Firneisz, K. A. Roebuck, and T. T. Glant Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human Osteoblasts J. Biol. Chem., May 3, 2002; 277(19): 16879 - 16887. [Abstract] [Full Text] [PDF]

				S.C. Manolagas, S. Kousteni, and R.L. Jilka Sex Steroids and Bone Recent Prog. Horm. Res., January 1, 2002; 57(1): 385 - 409. [Abstract] [Full Text] [PDF]

				M. A. Karsdal, M. S. Fjording, N. T. Foged, J.-M. Delaisse, and A. Lochter Transforming Growth Factor-beta -induced Osteoblast Elongation Regulates Osteoclastic Bone Resorption through a p38 Mitogen-activated Protein Kinase- and Matrix Metalloproteinase-dependent Pathway J. Biol. Chem., October 12, 2001; 276(42): 39350 - 39358. [Abstract] [Full Text] [PDF]

				C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text]

				S. C. Manolagas Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis Endocr. Rev., April 1, 2000; 21(2): 115 - 137. [Abstract] [Full Text]

				O. A. Adebanjo, B. S. Moonga, T. Yamate, L. Sun, C. Minkin, E. Abe, and M. Zaidi Mode of Action of Interleukin-6 on Mature Osteoclasts. Novel Interactions with Extracellular Ca2+ Sensing in the Regulation of Osteoclastic Bone Resorption J. Cell Biol., September 7, 1998; 142(5): 1347 - 1356. [Abstract] [Full Text] [PDF]

				T. Bellido, C. A. O'Brien, P. K. Roberson, and S. C. Manolagas Transcriptional Activation of the p21WAF1,CIP1,SDI1 Gene by Interleukin-6 Type Cytokines. A PREREQUISITE FOR THEIR PRO-DIFFERENTIATING AND ANTI-APOPTOTIC EFFECTS ON HUMAN OSTEOBLASTIC CELLS J. Biol. Chem., August 14, 1998; 273(33): 21137 - 21144. [Abstract] [Full Text] [PDF]

				T. Bellido, M. Huening, M. Raval-Pandya, S. C. Manolagas, and S. Christakos Calbindin-D28k Is Expressed in Osteoblastic Cells and Suppresses Their Apoptosis by Inhibiting Caspase-3 Activity J. Biol. Chem., August 18, 2000; 275(34): 26328 - 26332. [Abstract] [Full Text] [PDF]